<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04228341</url>
  </required_header>
  <id_info>
    <org_study_id>2018/01079</org_study_id>
    <nct_id>NCT04228341</nct_id>
  </id_info>
  <brief_title>The Effect of Degree of Rice-polishing on Glycaemic Response</brief_title>
  <official_title>The Effect of Degree of Rice-polishing on Glycaemic Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Nutrition Research Centre, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Nutrition Research Centre, Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effects of rice polishing on glycaemic and insulinaemic response in
      healthy Chinese male volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There will be a total of 8 test session. Each session will last for 3.5 hours. At each test
      session, volunteers will be served with test meal and blood will be collected. After an
      overnight fast, subjects will visit the research center. Two fasting capillary blood samples
      will be collected via fingerprick. Following the fasting samples, subject will consume the
      test meals. Further blood samples will be collected at 15, 30, 45, 60, 90, 120, 150, 180
      minutes after the ingestion of test meal. These samples will be used to analyses for whole
      capillary blood glucose. At every 30 minute interval, samples will be collected for analysis
      of capillary plasma insulin.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 13, 2019</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized crossover design</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose</measure>
    <time_frame>Up to 180 minutes</time_frame>
    <description>Whole capillary blood glucose will be measure using Hemocue analyser</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Up to 180 minutes</time_frame>
    <description>Capillary plasma will be measure using Cobas analyser</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Glucose Reference 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Glucose solution 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose Reference 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Glucose solution 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose Reference 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Glucose solution 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brown Rice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooked brown rice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 % polished rice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooked 3 % polished rice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6 % polished rice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooked 6 % polished rice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>9 % polished rice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>9 % polished rice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 % Polished rice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cooked 20 % Polished rice (White Rice)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose Reference 1</intervention_name>
    <description>50 g of glucose dissolved in 250 ml of water (First glucose control visit)</description>
    <arm_group_label>Glucose Reference 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose Reference 2</intervention_name>
    <description>50 g of glucose dissolved in 250 ml of water (Second glucose control visit)</description>
    <arm_group_label>Glucose Reference 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose Reference 3</intervention_name>
    <description>50 g of glucose dissolved in 250 ml of water (Third glucose control visit)</description>
    <arm_group_label>Glucose Reference 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brown Rice</intervention_name>
    <description>Unpolished brown rice containing 50 g of available carbohydrate was cooked using a rice cooker (Toyomi) at a ratio of rice to water of 1: 2</description>
    <arm_group_label>Brown Rice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 % polished rice</intervention_name>
    <description>3% polished rice, containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2</description>
    <arm_group_label>3 % polished rice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>6 % polished rice</intervention_name>
    <description>6% polished rice, containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2</description>
    <arm_group_label>6 % polished rice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>9 % polished rice</intervention_name>
    <description>9 % polished rice, containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2</description>
    <arm_group_label>9 % polished rice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>20 % Polished rice</intervention_name>
    <description>White rice (20% polished rice), containing 50 g of available carbohydrate was cooked using a rice cooker at a ratio of rice to water of 1: 2.</description>
    <arm_group_label>20 % Polished rice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  Chinese ethnicity

          -  Age ≥21 and ≤ 60 years

          -  Body mass index between 18.5 to 25 kg/m2

          -  Normal blood pressure =&lt;140/90 mmHg

          -  Fasting blood glucose &lt;6.0 mmol/L

          -  In general good health

        Exclusion Criteria:

          -  Current smoker

          -  Have any metabolic diseases (such as diabetes, hypertension etc)

          -  Do not have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)

          -  Have medical conditions and/or taking medications known to affect glycaemia
             (glucocorticoids, thyroid hormones, thiazide diuretics)

          -  Have intolerances or allergies to any foods

          -  Currently partake in sports at the competitive and/or endurance levels

          -  Intentionally restrict food intake
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male only</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Nutrition Research Centre</name>
      <address>
        <city>Singapore</city>
        <zip>117599</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 11, 2020</study_first_submitted>
  <study_first_submitted_qc>January 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2020</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Nutrition Research Centre, Singapore</investigator_affiliation>
    <investigator_full_name>JeyaKumar Henry</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

